Vivanza Biosciences Ltd — Updates, 02-05-2025: Company Update

Vivanza Biosciences Limited has announced that it is not required to submit the Annual Secretarial Compliance Report for the year, as its paid-up equity share capital of ₹4 Cr and net worth of approximately ₹4.68 Cr fall below the specified thresholds. This exempts the company from certain corporate governance compliance provisions, reflecting its current size and status. This update clarifies compliance requirements, ensuring shareholders and stakeholders are aware of the company’s regulatory standing without impacting its core operations.